Premium Nahrungsergänzungsmittel | artgerecht

Antinuclear Antibodies (ANA) – Definition & Significance

Antinuclear antibodies (ANA) are autoantibodies directed against components of the cell nucleus. Their detection in the blood is an important indicator of autoimmune diseases such as lupus erythematosus.

Regular tips about health Regular tips about health

Things worth knowing about "Antinuclear Antibodies"

Antinuclear antibodies (ANA) are autoantibodies directed against components of the cell nucleus. Their detection in the blood is an important indicator of autoimmune diseases such as lupus erythematosus.

What Are Antinuclear Antibodies?

Antinuclear antibodies (ANA) are antibodies produced by the immune system that mistakenly target components of the cell nucleus. Under normal circumstances, the immune system only attacks foreign substances such as bacteria or viruses. In certain autoimmune conditions, however, the immune system turns against the body´s own structures – including proteins, DNA, and other molecules found in the cell nucleus. These misdirected antibodies are known as antinuclear antibodies.

ANA can be detected in a wide range of autoimmune diseases, but they may also appear at low titers (concentrations) in healthy individuals, particularly in older adults.

Clinical Significance

The detection of ANA in the blood is an important diagnostic marker. A positive ANA test alone does not establish a diagnosis, but rather serves as a starting point for further investigation. Elevated ANA levels may indicate the following conditions:

Systemic lupus erythematosus (SLE): Positive in more than 95% of affected individuals
Sjogren syndrome: Autoimmune condition affecting the salivary and tear glands
Systemic sclerosis (scleroderma): A connective tissue disease
Polymyositis / dermatomyositis: Inflammatory muscle diseases
Mixed connective tissue disease (MCTD): An overlapping connective tissue disorder
Rheumatoid arthritis: Inflammatory joint disease
Autoimmune hepatitis: Inflammatory liver disease

Diagnosis: The ANA Test

The ANA test is performed on a blood sample. The most widely used method is indirect immunofluorescence (IIF), in which the patient´s serum is applied to cell cultures. Under the microscope, characteristic fluorescence patterns become visible, which can provide clues about the type of autoimmune disease present:

Homogeneous pattern: Commonly associated with SLE
Speckled pattern: Typical of Sjogren syndrome, MCTD, or scleroderma
Nucleolar pattern: May indicate systemic sclerosis
Centromere pattern: Typical of limited scleroderma (CREST syndrome)

The titer (dilution level) of the test reflects the concentration of antibodies. A titer of 1:160 or higher is generally considered clinically significant, although lower titers may also be relevant in certain clinical contexts.

Further Diagnostic Testing

A positive ANA result often leads to more specific antibody tests to help narrow down the diagnosis:

Anti-dsDNA antibodies: Specific for systemic lupus erythematosus
Anti-Smith (anti-Sm) antibodies: Also highly specific for SLE
Anti-SSA/Ro and anti-SSB/La: Characteristic of Sjogren syndrome
Anti-Scl-70 (topoisomerase I): Marker for diffuse scleroderma
Anti-Jo-1: Marker for polymyositis / dermatomyositis
Anti-U1-RNP: Characteristic of mixed connective tissue disease

When Should an ANA Test Be Performed?

An ANA test is recommended when symptoms suggest a possible autoimmune condition. These may include:

Persistent joint pain or swelling
Unexplained skin rashes, especially a butterfly-shaped rash on the face
Chronic fatigue and exhaustion without a clear cause
Dryness of the eyes and mouth
Raynaud phenomenon (color changes in the fingers triggered by cold)
Muscle pain or weakness
Unexplained hair loss or mouth sores

Interpreting the Results

A positive ANA test does not necessarily mean that an autoimmune disease is present. Up to 20% of the healthy population may have a weakly positive ANA result, particularly older individuals. Certain medications (e.g., hydralazine, procainamide) and infectious diseases can also produce a positive result.

A negative ANA test makes certain autoimmune diseases such as SLE very unlikely, but does not entirely rule them out. Results must always be interpreted in the context of the complete clinical picture.

References

Tan, E. M. et al. - The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis and Rheumatism, 25(11), 1271–1277.
Meroni, P. L. & Schur, P. H. - ANA screening: an old test with new recommendations. Annals of the Rheumatic Diseases, 69(8), 1420–1422 (2010).
Agmon-Levin, N. et al. - International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Annals of the Rheumatic Diseases, 73(1), 17–23 (2014).

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.